drugset / Trial / NCT01110018
GSK573719 IV Enabling Study
Non-randomizedSingle-groupOpen-labelTreatment
Summary
A single-centre, open-label, sequential, cross-over study to examine the safety, tolerability and pharmacokinetics of 3 ascending single intravenous doses, a single 1000μg oral dose and a single 1000μg inhaled dose of GSK573719 in healthy male volunteers.
Timeline
- Start
- 2010-04-28
- Primary completion
- 2010-06-09
- Completion
- 2010-06-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Umeclidinium | Other / unclassified | 20 ug | Intravenous |
| Comparator | Umeclidinium | Other / unclassified | 50 ug | Intravenous |
| Comparator | Umeclidinium | Other / unclassified | 100 ug | Intravenous |
| Comparator | Umeclidinium | Other / unclassified | 1000 ug | Intravenous |